SCHEMBL18723291

SCHEMBL18723291

CC(C)(CCC(=O)O)OCCC(C)(C)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19450560 0.90 — —
SCHEMBL18595868 0.88 — —
SCHEMBL20283890 0.88 — —
SCHEMBL18868578 0.83 — —
SCHEMBL21322779 0.83 — —
SCHEMBL21558321 0.83 — —
SCHEMBL22413689 0.80 GAA (0.31) —
SCHEMBL19303504 0.80 MGLL (0.32) —
SCHEMBL8606715 0.80 PTGER3 (0.37) —
SCHEMBL23315749 0.79 ALDH1A1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11116816-B2 Therapeutic vitamin d conjugates EXTEND BIOSCIENCES, INC. (US) 2021-09-14 — — US disclosed
WO-2021046112-A1 AMINOQUINOLINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2021-03-11 — — WO disclosed
WO-2020252254-A1 MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS BOLT BIOTHERAPEUTICS, INC. (US) 2020-12-17 — — WO disclosed
US-20190183966-A1 THERAPEUTIC VITAMIN D CONJUGATES EXTEND BIOSCIENCES, INC. (US) 2019-06-20 — — US disclosed
US-9616109-B2 Insulin vitamin D conjugates EXTEND BIOSCIENCES, INC. (US) 2017-04-11 — — US disclosed
Send feedback